  Despite recent advances in our ability to detect adaptive evolution involving
the cis-regulation of gene expression, our knowledge of the molecular
mechanisms underlying these adaptations has lagged far behind. Across all model
organisms the causal mutations have been discovered for only a handful of gene
expression adaptations, and even for these, mechanistic details (e.g. the
trans-regulatory factors involved) have not been determined. We previously
reported a polygenic gene expression adaptation involving down-regulation of
the ergosterol biosynthesis pathway in the budding yeast Saccharomyces
cerevisiae. Here we investigate the molecular mechanism of a cis-acting
mutation affecting a member of this pathway, ERG28. We show that the causal
mutation is a two-base deletion in the promoter of ERG28 that strongly reduces
the binding of two transcription factors, Sok2 and Mot3, thus abolishing their
regulation of ERG28. This down-regulation increases resistance to a widely used
antifungal drug targeting ergosterol, similar to mutations disrupting this
pathway in clinical yeast isolates. The identification of the causal genetic
variant revealed that the selection likely occurred after the deletion was
already present at high frequency in the population, rather than when it was a
new mutation. These results provide a detailed view of the molecular mechanism
of a cis-regulatory adaptation, and underscore the importance of this view to
our understanding of evolution at the molecular level.
